North China Pharmaceutical Co.

Chart & Performance

D1W1MN

P/E

43.21

P/S

0.86

EPS

0.11

Div Yield, %

0.67%

Shrs. gr., 5y

1.02%

Rev. gr., 5y

-4.27%

Revenues

9.24b

-6.36%

Net income

183m

+44.15%

CFO

1.18b

-4.31%

Dividend

Jul 25, 20250.03 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

North China Pharmaceutical Company Ltd. is a Chinese firm specializing in the chemical pharmaceutical sector. Its extensive product range primarily features anti-infective medications, supplied as active pharmaceutical ingredients (APIs), their intermediates, and final preparations. The company's offerings further encompass biotechnological therapeutics, drugs for cardiovascular conditions, immunomodulators, vitamin-based consumer health products, and specialized pharmaceuticals for agricultural and veterinary applications. Founded in 1953, North China Pharmaceutical Company Ltd. maintains its headquarters in Shijiazhuang, China.

URL

http://www.ncpc.com

IPO date

Jan 14, 1994

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT